Michael S. Awadalla
Michael S. Awadalla, PharmD, BCGP, is executive vice president, Office of Applied Pharmacotherapy, at Tabula Rasa HealthCare, a health care technology company advancing the safe use of medications.
Articles
July 27th 2022
Contributor: How Medication Risk Scores Improve Health for Medicare Beneficiaries
Medication risk scores analyze an individual’s medication regimen to look for the potential for simultaneous, multi-drug interactions, which can cause adverse drug events and other medication-related harms.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: October 11th 2024 | Updated: November 21st 2024
NCCN Guidelines for MPN Reflect New Drugs, Focus on Clinical Trials
